PBK drives PARP inhibitor resistance through the TRIM37/NFκB axis in ovarian cancer

Hanlin Ma(Qilu Hospital of Shandong University), Beihua Kong(Qilu Hospital of Shandong University)
Experimental & Molecular Medicine
July 20, 2022
Cited by 28


Related Papers